Overall rank by patents
#37,000
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, active 2016–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A46B (BRUSHES).
The verdict
Pet's holds 7 US patents across 4 technology areas, rank #37,000 of 50,000 tracked assignees.
Pet's Best Life, L.l.c. has been granted 7 US utility patents between 2016 and 2022, placing Pet's Best Life, L.l.c. at rank #37,000 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 4.0 claims per patent with primary concentration in A46B (BRUSHES). As a US Corporation, Pet's Best Life, L.l.c. is one of the more focused assignees in the PatentsView dataset. By volume, Pet's sits between Performance Systematix Llc (7 patents, rank #36,996) and Phase IV Engineering Inc. (7 patents, rank #37,004) - the closest US assignees by grant volume. The composite Innovation Score of 23.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 3 in the 2015–2019 window, a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Pet's Best Life, L.l.c.'s 4.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Pet's Best Life, L.l.c. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Performance Systematix LLC
7 patents
Perma Pure LLC
7 patents
Pernod Ricard SA
7 patents
Perosphere Technologies Inc.
7 patents
PetroQuip Energy Services, LLC
7 patents
PharmaSeq, Inc.
7 patents
Pharmaceutical Manufacturing Research Services, Inc.
7 patents
Phase IV Engineering Inc.
7 patents
Pet's Best Life, L.L.C.
7 patents
What this shows Pet's holds 7 patents at rank #37,000, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #37,000 in granted patent volume.
Other assignees with the most granted patents in Pet's's primary technology class.
Pet's's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
23 Top 88% higher than 12% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 28.6% |
| 2017 | 1 | 14.3% |
| 2020 | 1 | 14.3% |
| 2021 | 1 | 14.3% |
| 2022 | 2 | 28.6% |
Top 4 of 4 technology areas
Overall rank by patents
#37,000
Across all tracked assignees
23.3 out of 100
How to use this portfolio
Pet's's 7 grants land it in the top 88% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.